Suppr超能文献

肠道微生物群与炎症性肠病:因果关系还是相关性?

Gut microbiota and IBD: causation or correlation?

作者信息

Ni Josephine, Wu Gary D, Albenberg Lindsey, Tomov Vesselin T

机构信息

Division of Gastroenterology, Perelman School of Medicine, University of Pennsylvania, 421 Curie Boulevard, 914 BRB II/III, Philadeplhia, Pennsylvania 19104, USA.

Division of Gastroenterology, Hepatology, and Nutrition, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104, USA.

出版信息

Nat Rev Gastroenterol Hepatol. 2017 Oct;14(10):573-584. doi: 10.1038/nrgastro.2017.88. Epub 2017 Jul 19.

Abstract

A general consensus exists that IBD is associated with compositional and metabolic changes in the intestinal microbiota (dysbiosis). However, a direct causal relationship between dysbiosis and IBD has not been definitively established in humans. Findings from animal models have revealed diverse and context-specific roles of the gut microbiota in health and disease, ranging from protective to pro-inflammatory actions. Moreover, evidence from these experimental models suggest that although gut bacteria often drive immune activation, chronic inflammation in turn shapes the gut microbiota and contributes to dysbiosis. The purpose of this Review is to summarize current associations between IBD and dysbiosis, describe the role of the gut microbiota in the context of specific animal models of colitis, and discuss the potential role of microbiota-focused interventions in the treatment of human IBD. Ultimately, more studies will be needed to define host-microbial relationships relevant to human disease and amenable to therapeutic interventions.

摘要

目前已形成一种普遍共识,即炎症性肠病(IBD)与肠道微生物群的组成和代谢变化(生态失调)有关。然而,生态失调与IBD之间的直接因果关系在人类中尚未得到明确证实。动物模型的研究结果揭示了肠道微生物群在健康和疾病中具有多样且因具体情况而异的作用,范围从保护作用到促炎作用。此外,这些实验模型的证据表明,尽管肠道细菌常常驱动免疫激活,但慢性炎症反过来会塑造肠道微生物群并导致生态失调。本综述的目的是总结IBD与生态失调之间的当前关联,描述肠道微生物群在特定结肠炎动物模型中的作用,并讨论以微生物群为重点的干预措施在人类IBD治疗中的潜在作用。最终需要更多研究来确定与人类疾病相关且适合进行治疗干预措施的宿主-微生物关系

相似文献

1
Gut microbiota and IBD: causation or correlation?
Nat Rev Gastroenterol Hepatol. 2017 Oct;14(10):573-584. doi: 10.1038/nrgastro.2017.88. Epub 2017 Jul 19.
2
Links Between Inflammatory Bowel Disease and Chronic Obstructive Pulmonary Disease.
Front Immunol. 2020 Sep 11;11:2144. doi: 10.3389/fimmu.2020.02144. eCollection 2020.
3
4
Inflammatory Bowel Diseases (IBD) and the Microbiome-Searching the Crime Scene for Clues.
Gastroenterology. 2021 Jan;160(2):524-537. doi: 10.1053/j.gastro.2020.09.056. Epub 2020 Nov 27.
5
The Microbiota and the Immune Response: What Is the Chicken and What Is the Egg?
Gastrointest Endosc Clin N Am. 2019 Jul;29(3):381-393. doi: 10.1016/j.giec.2019.02.005. Epub 2019 Apr 5.
6
Gut microbiome in primary sclerosing cholangitis: A review.
World J Gastroenterol. 2020 Jun 7;26(21):2768-2780. doi: 10.3748/wjg.v26.i21.2768.
8
The gut microbiota heterogeneity and assembly changes associated with the IBD.
Sci Rep. 2019 Jan 24;9(1):440. doi: 10.1038/s41598-018-37143-z.
9
The interplay between host immune cells and gut microbiota in chronic inflammatory diseases.
Exp Mol Med. 2017 May 26;49(5):e339. doi: 10.1038/emm.2017.24.
10
Enteroendocrine Cells: Sensing Gut Microbiota and Regulating Inflammatory Bowel Diseases.
Inflamm Bowel Dis. 2020 Jan 1;26(1):11-20. doi: 10.1093/ibd/izz217.

引用本文的文献

1
Quercetin boosts gut microbiota-driven production of isovanillic acid to alleviate colitis via enhancing intestinal barrier function.
Curr Res Food Sci. 2025 Aug 23;11:101183. doi: 10.1016/j.crfs.2025.101183. eCollection 2025.
2
Identification and applications of disease-associated differential human and bacterial proteins with metaproteomic evidence.
Health Inf Sci Syst. 2025 Aug 29;13(1):54. doi: 10.1007/s13755-025-00369-z. eCollection 2025 Dec.
6
Enrichment of short-chain fatty acid-producing bacteria by pH-responsive sodium alginate and chitosan-encapsulated quercetin.
Front Microbiol. 2025 Aug 6;16:1594012. doi: 10.3389/fmicb.2025.1594012. eCollection 2025.
8
Microbiota composition-based donor selection affects FMT efficacy in a murine colitis model.
Front Immunol. 2025 Aug 1;16:1635244. doi: 10.3389/fimmu.2025.1635244. eCollection 2025.
10

本文引用的文献

1
Indexed Pain Journals.
J Pain Palliat Care Pharmacother. 2008;22(1):45-46. doi: 10.1080/15360280801989377.
2
A member of the gut mycobiota modulates host purine metabolism exacerbating colitis in mice.
Sci Transl Med. 2017 Mar 8;9(380). doi: 10.1126/scitranslmed.aaf9044.
3
Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial.
Lancet. 2017 Mar 25;389(10075):1218-1228. doi: 10.1016/S0140-6736(17)30182-4. Epub 2017 Feb 15.
4
Dynamics of the human gut microbiome in inflammatory bowel disease.
Nat Microbiol. 2017 Feb 13;2:17004. doi: 10.1038/nmicrobiol.2017.4.
5
Host-Microbiota Interactions Shape Local and Systemic Inflammatory Diseases.
J Immunol. 2017 Jan 15;198(2):564-571. doi: 10.4049/jimmunol.1601621.
6
Understanding and Preventing the Global Increase of Inflammatory Bowel Disease.
Gastroenterology. 2017 Feb;152(2):313-321.e2. doi: 10.1053/j.gastro.2016.10.020. Epub 2016 Oct 25.
7
Diet as a Trigger or Therapy for Inflammatory Bowel Diseases.
Gastroenterology. 2017 Feb;152(2):398-414.e6. doi: 10.1053/j.gastro.2016.10.019. Epub 2016 Oct 25.
8
Prevalence of Inflammatory Bowel Disease Among Adults Aged ≥18 Years - United States, 2015.
MMWR Morb Mortal Wkly Rep. 2016 Oct 28;65(42):1166-1169. doi: 10.15585/mmwr.mm6542a3.
9
Association of host genome with intestinal microbial composition in a large healthy cohort.
Nat Genet. 2016 Nov;48(11):1413-1417. doi: 10.1038/ng.3693. Epub 2016 Oct 3.
10
Crosstalk between autophagy and inflammatory signalling pathways: balancing defence and homeostasis.
Nat Rev Immunol. 2016 Nov;16(11):661-675. doi: 10.1038/nri.2016.100. Epub 2016 Oct 3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验